IIb |
Type 1 Diabetes |
Drug |
15 |
167 |
US |
Full Scope |
I |
Type 1 Diabetes |
Drug |
1 |
24 |
US |
Full Scope |
IIa |
Type 2 Diabetes |
Drug |
2 |
30 |
US |
Full Scope |
I / II |
Type 2 Diabetes |
Drug |
2 |
37 |
US |
DM, Biostatistics, PM |
II |
Type 2 Diabetes |
Drug |
1 |
10 |
US |
Full Scope |
II |
Diabetes |
Continuous Insulin Delivery Device |
10 |
60 |
US |
Full Scope |
II |
Type 2 Diabetes, Hypertension |
Drug |
10 |
72 |
US |
PM, Monitoring |
II |
Type 2 Diabetes |
Drug |
12 |
75 |
US |
Full Scope |
II |
Type 2 Diabetes |
Drug |
12 |
82 |
US |
Full Scope |
II |
Diabetes |
Drug |
13 |
86 |
US |
PM, Monitoring, Medical |
II |
Type 2 Diabetes |
Drug |
22 |
150 |
US |
Full Scope |
II |
Insulin Dependent Diabetes |
Drug |
30 |
300 |
US, Europe |
Full Scope |
II |
Insulin Dependent Diabetes |
Drug |
32 |
300 |
US |
Full Scope |
II |
Type 2 Diabetes |
Drug |
33 |
194 |
US |
Full Scope |
II |
Type 2 Diaebetes Nephropathy |
Drug |
40 |
170 |
US |
DM, PM, Medical, Monitoring |
IIa |
Type 2 Diabetes |
Drug |
8 |
52 |
US |
Full Scope |
IIa |
Type 2 Diabetes |
Drug |
14 |
110 |
US |
Medical, PM, Monitoring |
IIb |
Type 2 Diabetes |
Drug |
20 |
191 |
US, Europe |
Full Scope |
IIb |
Type 2 Diabetes |
Drug |
24 |
180 |
US |
Full Scope |
III |
Diabetes |
Drug |
29 |
222 |
S. Africa |
Medical, PM, Monitoring |
III |
Type 2 Diabetes |
Drug |
150 |
1000 |
S. Africa, India, Europe |
PM, Monitoring, Medical |
IV |
Type 2 Diabetes |
Drug |
2 |
34 |
US |
Full Scope |
IV |
Type 2 Diabetes |
Drug |
5 |
55 |
US |
Full Scope |
IV |
Type 2 Diabetes, Hypertension |
Drug |
25 |
250 |
US |
Full Scope |
IV |
Diabetes |
Drug |
45 |
350 |
US |
Full Scope |
IV |
Type 2 Diabetes |
Drug |
132 |
1009 |
US, Canada |
PM, Monitoring, Medical |
IV |
Type 2 Diabetes |
Drug |
145 |
900 |
US, S. Africa |
PM, Monitoring, Medical, DM |